Cargando…

Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells

Nanoparticles based on the biocompatible amphiphilic poly(N-vinylpyrrolidone) (Amph-PVP) derivatives are promising for drug delivery. Amph-PVPs self-aggregate in aqueous solutions with the formation of micellar nanoscaled structures. Amph-PVP nanoparticles are able to immobilize therapeutic molecule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yagolovich, Anne, Kuskov, Andrey, Kulikov, Pavel, Kurbanova, Leily, Bagrov, Dmitry, Artykov, Artem, Gasparian, Marine, Sizova, Svetlana, Oleinikov, Vladimir, Gileva, Anastasia, Kirpichnikov, Mikhail, Dolgikh, Dmitry, Markvicheva, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464842/ https://www.ncbi.nlm.nih.gov/pubmed/34575490 http://dx.doi.org/10.3390/pharmaceutics13091413

Ejemplares similares

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2021)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2022)

Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Doxorubicin-Loaded Polyelectrolyte Multilayer Capsules Modified with Antitumor DR5-Specific TRAIL Variant for Targeted Drug Delivery to Tumor Cells
por: Gileva, Anastasia, et al.
Publicado: (2023)

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
por: Yagolovich, Anne V., et al.
Publicado: (2020)

Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors
por: Artykov, Artem A., et al.
Publicado: (2020)

Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
por: Bychkov, Maxim L., et al.
Publicado: (2014)

Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway
por: Yagolovich, Anne V., et al.
Publicado: (2023)

Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study
por: Kuskov, Andrey, et al.
Publicado: (2022)

Macromolecular Design and Engineering of New Amphiphilic N-Vinylpyrrolidone Terpolymers for Biomedical Applications
por: Kurmaz, Svetlana V., et al.
Publicado: (2023)

New Nanosized Systems Doxorubicin—Amphiphilic Copolymers of N-Vinylpyrrolidone and (Di)methacrylates with Antitumor Activity
por: Kurmaz, Svetlana V., et al.
Publicado: (2022)

In Vitro Assessment of Poly-N-Vinylpyrrolidone/Acrylic Acid Nanoparticles Biocompatibility in a Microvascular Endothelium Model
por: Berdiaki, Aikaterini, et al.
Publicado: (2022)

Design and Investigation of New Water-Soluble Forms of α-Tocopherol with Antioxidant and Antiglycation Activity Using Amphiphilic Copolymers of N-Vinylpyrrolidone
por: Soldatova, Yuliya V., et al.
Publicado: (2023)

Amphiphilic Copolymers Containing POSS and SBMA with N-Vinylcaprolactam and N-Vinylpyrrolidone for THF Hydrate Inhibition
por: Li, Chuan, et al.
Publicado: (2018)

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
por: Qiao, Chunxia, et al.
Publicado: (2012)

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
por: Dubuisson, Agathe, et al.
Publicado: (2017)

Nanoparticles of N-Vinylpyrrolidone Amphiphilic Copolymers and Pheophorbide a as Promising Photosensitizers for Photodynamic Therapy: Design, Properties and In Vitro Phototoxic Activity
por: Rybkin, Alexander Yu., et al.
Publicado: (2023)

First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
por: Wang, Shujing, et al.
Publicado: (2021)

Self-Assembly and Enzyme Responsiveness of Amphiphilic Linear-Dendritic Block Copolymers Based on Poly(N-vinylpyrrolidone) and Dendritic Phenylalanyl-lysine Dipeptides
por: Wei, Junwu, et al.
Publicado: (2019)

Conozca a DR DOS 5.0
por: Schieb, Joerg
Publicado: (1992)

Dr Quain's Anatomy; 5th Edition
Publicado: (1846)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
por: van Geelen, Caroline MM, et al.
Publicado: (2011)

Expression of DR4, DR5, FAS, Caspase-8 and, DDIAS Genes in AML Patients
por: Naghinezhad, Jalal, et al.
Publicado: (2023)

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
por: Oh, You-Take, et al.
Publicado: (2017)

In memory of Dr. Javad Ashjaee (1949–2020)
por: Leick, Alfred, et al.
Publicado: (2020)

Enigmatic mechanism of the N-vinylpyrrolidone hepatocarcinogenicity in the rat
por: Oesch, Franz, et al.
Publicado: (2021)

Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization
por: Dubuisson, Agathe, et al.
Publicado: (2019)

Dr. Paris, Dr. Beck, Dr. Smith, Dr. Male and Others, on Infanticide
Publicado: (1824)

Mesoporous Networks of N-Vinylpyrrolidone with (di)Methacrylates as Precursors of Ecological Molecular Imprinted Polymers
por: Kurmaz, Svetlana V., et al.
Publicado: (2021)

New Conjugates Based on AIS/ZnS Quantum Dots and Aluminum Phthalocyanine Photosensitizer: Synthesis, Properties and Some Perspectives
por: Yakovlev, Dmitry, et al.
Publicado: (2022)

Dr. Storer on Dr. Simpson
Publicado: (1870)

Kentucky: Death of Dr. Miller, Dr. Linthicum, and Dr. Cosby
Publicado: (1867)

Necrological: Dr. Wagley, Dr. Paine, Dr. DeSteiger
Publicado: (1894)

Response to Dr Fried & Dr Kievit, and Dr Malhi et al.
por: Schmaal, L, et al.
Publicado: (2016)

Medical Obituaries—Dr. McClellan—Dr. Cooke—Dr. Howard
Publicado: (1854)

Differential expression of predisposing HLA-DQ2.5 alleles in DR5/DR7 celiac disease patients affects the pathological immune response to gluten
por: Pisapia, Laura, et al.
Publicado: (2020)

Dr. Miller in Reply to Dr. Patterson
por: Patterson, W.
Publicado: (1803)

Dr. Littlehales and Dr. Fowler, on the Influenza
por: Beddoes, Thomas
Publicado: (1803)

Dr. Walker, on Dr. Jenner's Diploma
por: Walker, John
Publicado: (1805)

Cannot write session to /tmp/vufind_sessions/sess_4s0ltep6erv5471g6jcrsrqgiq